WeVote
Log In

Bill

Bill

HB 721

Step-therapy Protocols

2025 Regular Session Introduced by Karen Gonzalez Pittman

HB 721 would restrict insurance step-therapy protocols requiring cheaper drugs first, but died in committee without clarification of specific restrictions or patient protections.

Died in Health Care Facilities & Systems Subcommittee
#subjectindex
0
WeVote Research Nonpartisan
Bill Summary · HB 721

Legislative bill overview

HB 721 addresses step-therapy protocols, which are insurance requirements that patients try lower-cost medications before accessing more expensive treatments. The bill would impose restrictions on how insurance companies and pharmacy benefit managers can implement these protocols in Florida. The legislation died in committee without advancing to a floor vote.

Why is this important

Step-therapy requirements affect patient access to medications and can delay treatment for serious conditions. These protocols significantly impact healthcare costs, patient outcomes, and the relationship between insurers, providers, and patients. The debate reflects tension between controlling healthcare expenses and ensuring timely access to necessary medications.

Potential points of contention

  • Patient access vs. cost control: Restrictions on step-therapy could increase insurance premiums and healthcare costs, while protections may be necessary to prevent delays in treating urgent conditions
  • Medical autonomy: Whether insurance companies or physicians should have final authority on medication sequencing and treatment decisions
  • Scope of restrictions: What safeguards would be required (emergency exceptions, physician appeals processes) and whether they impose administrative burdens on insurers and providers

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.